Peixin Dong
Dr. Dong Peixin is interested in the epigenetic and genetic mechanisms that underpin cancer stem cells, EMT, chemoresistance, and cancer metastasis. Dr. Dong has developed expertise via more than 70 papers in international journals. Dr. Dong is an Associate Editor for the journals Frontiers in Pharmacology, Frontiers in Oncology, BMC Cancer, Journal of Cellular and Molecular Medicine, and Current Gene Therapy. Dr. Dong is also a member of the Editorial Boards of Clinical & Experimental Metastasis, PLOS ONE, Genes, Biomolecules, Bioengineered, Chinese Clinical Oncology, and Gynecology and Pelvic Medicine. Dr. Dong has earned several awards for his contributions to the field.
